Skip to main content

Peer Review reports

From: Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

Original Submission
25 Nov 2020 Submitted Original manuscript
22 Dec 2020 Reviewed Reviewer Report
28 Dec 2020 Reviewed Reviewer Report
3 Jan 2021 Reviewed Reviewer Report
5 Jan 2021 Reviewed Reviewer Report
7 Feb 2021 Author responded Author comments - Markus Hecht
Resubmission - Version 2
7 Feb 2021 Submitted Manuscript version 2
8 Feb 2021 Author responded Author comments - Markus Hecht
Resubmission - Version 3
8 Feb 2021 Submitted Manuscript version 3
9 Feb 2021 Author responded Author comments - Markus Hecht
Resubmission - Version 4
9 Feb 2021 Submitted Manuscript version 4
19 Feb 2021 Reviewed Reviewer Report
21 Feb 2021 Reviewed Reviewer Report
22 Feb 2021 Reviewed Reviewer Report
22 Feb 2021 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
28 Feb 2021 Editorially accepted
24 Mar 2021 Article published 10.1186/s12885-021-08006-0

You can find further information about peer review here.

Back to article page